| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/17/2002 | CN1358749A Novel polypeptide-human epidernal growth factor 10.12 the polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358748A Novel polypeptide-human conjugated abberent molecule 10.23 anjd polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358747A Novel polypeptide-signal pathway related polyzinc finger protein 87.12 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358746A Novel polypeptide-Rab6 guanopterin nucleoside triphosphate activating protein 69.41 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358745A Novel polypeptide-zinc finge rprotein ZNF 135-47.63 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358744A Novel polypeptide-homoeotic regional transcription factor 38.72 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358743A Novel polypeptide-ubiquitin protein 60.39 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358742A Novel polypeptide-ribosomal S4 16.28 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358741A Novel polypeptide-ribosomal protein S516.94 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358740A Novel polypeptide-PNA conjugated protein 11.44 the polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358739A Novel polypeptide-cytoskeleton related protein family 9.24 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358738A Novel polypeptide-leucine zipper containing EF maniform membrane-spanning protein 48.84 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358737A Novel polypeptide-zinc finger protein 15.29 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358736A Novel polypeptide-retina epithelia membrane protein 46.42, and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358735A Novel polypeptide-phosphoryl trasport protein 8.8 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1087747C Method for preparing medicine using silkworm produced recombined human thrombocytopoietic factor |
| 07/17/2002 | CN1087746C Method for preparing medicine using silkworm expressed recombined human erythropoietin |
| 07/17/2002 | CN1087631C Radiolabeled peptides for diagnosis and therapy |
| 07/17/2002 | CN1087630C Radiolabeled compounds for thrombus imaging |
| 07/16/2002 | US6420545 Nucleotide sequences coding polypeptide for use in the treatment of preferential viral diseases |
| 07/16/2002 | US6420544 Polynucleotide and polypeptide sequences encoding murine organic anion transporter 5 (mOATP5) |
| 07/16/2002 | US6420543 Nucleotide sequences coding preferential polypeptide for use in the treatment of immunological and cell proliferative defects |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420541 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 07/16/2002 | US6420540 Toxoplasma gondii antigens |
| 07/16/2002 | US6420534 Alzheimer's disease secretase, APP substrates therefor, and uses thereof |
| 07/16/2002 | US6420532 Binding to human y2 receptors and expression |
| 07/16/2002 | US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence |
| 07/16/2002 | US6420529 Chimeric protein with cytoplasmic kinase domain of yeast protein |
| 07/16/2002 | US6420527 Peoteins with modified amino acid sequences and monellin protein |
| 07/16/2002 | US6420525 Human transcription factor ZGCL-1 |
| 07/16/2002 | US6420523 Polypeptide expressed by an insect cell with baculovirus vector |
| 07/16/2002 | US6420521 Short gastrointestinal peptides |
| 07/16/2002 | US6420518 Insulin-like growth factor agonist molecules |
| 07/16/2002 | US6420345 Methods and reagents for inhibiting angiogenesis |
| 07/16/2002 | US6420340 Homogeneous preparation of protein, e.g. leptin, modified at the n-terminal only by an anhydride, e.g. succinic anhydride, ethylenediaminetetraacetic dianhydride; improved solubility; no inflammation at injection sites |
| 07/16/2002 | US6420339 Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| 07/16/2002 | US6420337 Protein isolated from egg whites and yolks of hyperimmunized animals; amino acid sequence seq id no:1 and 6; upregulation of tumor necrosis factor and interleukins-6 and -1beta; downregulation of transforming growth factor-beta |
| 07/16/2002 | US6420336 Purified antiviral protein, peptide or conjugate encoded by amino acid sequence 90% homologous to seq id no: 2; prophy-lactic or therapeutic inhibition of growth of a virus, such as a retrovirus; human immunodeficiency virus, hiv-1 or hiv-2 |
| 07/16/2002 | US6420188 Screening assay for the identification of inhibitors for macrophage migration inhibitory factor |
| 07/16/2002 | US6420175 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 07/16/2002 | US6420172 Method for inducing tumor immunity |
| 07/16/2002 | US6420171 Composite material for use in the isolation of aggregations of cells associate with preferential blood disorders |
| 07/16/2002 | US6420161 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides |
| 07/16/2002 | US6420160 Expression vector for use in immunotherapy and gene therapy |
| 07/16/2002 | US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis |
| 07/16/2002 | US6420141 Anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating aids |
| 07/16/2002 | US6420140 Production of multimeric protein by cell fusion method |
| 07/16/2002 | US6420137 Nucleotide sequences coding membrane protein for use treating diet defects and eating disorders |
| 07/16/2002 | US6420136 Controlling gene expression and propagation; obtain cell, incubate with modulator, monitor gene expression inhibition and antiproliferative activities |
| 07/16/2002 | US6420135 Streptococcus pneumoniae polynucleotides and sequences |
| 07/16/2002 | US6420134 Vaccines for nontypable haemophilus influenzae |
| 07/16/2002 | US6420124 KVLQT1—a long qt syndrome gene |
| 07/16/2002 | US6420120 Use of a polypeptide as cell receptor for adenoviruses |
| 07/16/2002 | US6420118 Monitoring activity of mutant tumor suppressor protein; obtain sample containing mutant peptide, incubate with wild type cell, monitor tumor suppression activity of cells |
| 07/16/2002 | US6420116 Protein for use in the human therapeutics and diagnosis |
| 07/16/2002 | US6420113 Chimeric polyclonal antibodies |
| 07/16/2002 | US6420106 Diagnosing uterine cancer in humans; obtain sample tissue, monitor viral nucleic acid concentration, amplified viral concentration indicates uterine canccer |
| 07/16/2002 | US6419933 Genetic engineered polypeptide |
| 07/16/2002 | US6419932 Antigen of hybrid M protein and carrier for Group A streptococccal vaccine |
| 07/16/2002 | US6419931 Compositions and methods for eliciting CTL immunity |
| 07/16/2002 | US6419929 Genetic engineering |
| 07/16/2002 | US6419927 Method for reducing adverse effects of a human 70kDa mediator which results from endotoxin stimulation of macrophages |
| 07/16/2002 | US6419925 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 07/16/2002 | US6419923 Filariid nematode cysteine protease proteins, and uses thereof |
| 07/16/2002 | US6419921 DNA-constructs of blood clotting factors and P-Selectin |
| 07/16/2002 | US6419920 Insoluble collagen matrix |
| 07/16/2002 | US6419918 Receptors of chemotactic peptide; leukemia therapy |
| 07/16/2002 | US6419917 Accumulation of eosinophils using polypeptides |
| 07/16/2002 | US6419846 Determining endpoint in etching processes using principal components analysis of optical emission spectra |
| 07/16/2002 | CA2286296C Inhibitors for urokinase receptor |
| 07/16/2002 | CA2253663C Hgh-rh(1-29)nh2 analogues having antagonistic activity |
| 07/16/2002 | CA2239360C G-csf analog compositions and methods |
| 07/16/2002 | CA2236158C Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/16/2002 | CA2193094C The cytoplasmic inhibition of gene expression |
| 07/16/2002 | CA2095926C Anti-human milk fat globule humanised antibodies |
| 07/16/2002 | CA2081559C Determination of analytes in biological fluids in the presence of substances interfering with assays therefor |
| 07/16/2002 | CA2059242C Coleopteran-active bacillus thuringiensis isolate and a novel gene encoding a coleopteran-active toxin |
| 07/16/2002 | CA2024063C Antibodies directed against nerve growth factor-like peptides |
| 07/16/2002 | CA1341376C Protein concentrate, method of making and method of using for therapeutic purposes, which forms a clot upon interacting with trombin |
| 07/11/2002 | WO2002054083A2 Alpha synuclein aggregation assays |
| 07/11/2002 | WO2002054080A2 Proteins, genes and their use for diagnosis and treatment of vascular response |
| 07/11/2002 | WO2002054072A2 Assay to determine efficacy of treatment for mycobacterial infection |
| 07/11/2002 | WO2002054066A2 Non-apoptotic forms of cell death and methods of modulation |
| 07/11/2002 | WO2002054065A2 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 07/11/2002 | WO2002053770A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/11/2002 | WO2002053765A1 Novel molecules of the card-related protein family and used thereof |
| 07/11/2002 | WO2002053761A2 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 07/11/2002 | WO2002053760A2 Chimeric cytolytic viruses for cancer treatment |
| 07/11/2002 | WO2002053757A1 Hiv-like particles and the use thereof |
| 07/11/2002 | WO2002053744A1 Banana actin gene and its promoter |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053741A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | WO2002053740A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | WO2002053739A2 Neuropilin homolog zcub5 |
| 07/11/2002 | WO2002053738A1 Novel proteins and dnas thereof |
| 07/11/2002 | WO2002053737A1 Nf-kb activating gene |
| 07/11/2002 | WO2002053736A1 Method of examining ability to control nerve cell plasticity |
| 07/11/2002 | WO2002053735A1 Trasncription activation complex and utilization thereof |